Viking Therapeutics (VKTX) Return on Capital Employed Growth (3y) (2018 - 2026)
Viking Therapeutics (VKTX) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 4,853.00 |
| 10 | Viking Therapeutics | 4.11 Bn | 4.11 Bn | - | -3,853.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,853.00 |
| Dec 31, 2025 | -1,213.00 |
| Sep 30, 2025 | 283.00 |
| Jun 30, 2025 | 838.00 |
| Mar 31, 2025 | 1,027.00 |
| Dec 31, 2024 | 982.00 |
| Sep 30, 2024 | 1,015.00 |
| Jun 30, 2024 | 864.00 |
| Mar 31, 2024 | 111.00 |
| Dec 31, 2023 | -1,108.00 |
| Sep 30, 2023 | -865.00 |
| Jun 30, 2023 | -1,650.00 |
| Mar 31, 2023 | -3,828.00 |
| Dec 31, 2022 | -3,664.00 |
| Sep 30, 2022 | -2,832.00 |
| Jun 30, 2022 | -2,392.00 |
| Mar 31, 2022 | -2,061.00 |
| Dec 31, 2021 | -1,795.00 |
| Sep 30, 2021 | -1,410.00 |
| Jun 30, 2021 | -264.00 |